New biopharma and med-tech financings were reported for the week of July 6, with several companies raising capital for development and commercialization activities. The slate includes Abivax, Celea, Elicio, and Tenon, according to the financings roundup. While the summary does not provide round sizes or terms for each company in the list itself, it signals ongoing investor activity across both clinical and platform-driven businesses. For portfolio managers, the key point is that despite market volatility, multiple companies are continuing to access public and private funding channels simultaneously. Investors will likely watch follow-on milestones tied to near-term clinical readouts referenced in company updates during the same period.